Stamford Pharmaceuticals Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $29.8M

  • Investors
  • 2

Stamford Pharmaceuticals General Information

Description

Operator of a cancer immunotherapy company intended to develop medicines to treat primary, recurrent and metastatic cancers. The company uses several different technologies and approaches utilizing viral vectors and affinity agents that can be conjugated to deliver biologicals, enabling doctors to utilize new and advanced treatments to cure patients even in advanced stages of cancer.

Contact Information

Formerly Known As
IgAvax, Ascend Biopharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 500 West 2nd Street
  • Suite 1900
  • Austin, TX 78701
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 500 West 2nd Street
  • Suite 1900
  • Austin, TX 78701
  • United States

Stamford Pharmaceuticals Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stamford Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 28-Sep-2023 $29.8M 0000 0000 Completed Clinical Trials - Phase 2
4. Secondary Transaction - Private 01-May-2021 00.000 Completed Pre-Clinical Trials
3. IPO 14-Nov-2014 Cancelled Pre-Clinical Trials
2. Seed Round 30-Nov-2012 $3.17M $3.17M 000.00 Completed Pre-Clinical Trials
1. Later Stage VC 01-Nov-2006 Completed Pre-Clinical Trials
To view Stamford Pharmaceuticals’s complete valuation and funding history, request access »

Stamford Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A-1 00,000,000 00.000000 00 00.00 00.00 00 00.00 000
Seed 5 00,000,000 00.000000 00.00 00.00 00 00.00 0.000
Seed 4 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Seed 3 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 2 19,340,867 $0.000100 $0.11 $0.11 1x $0.11 7.26%
Seed 1 22,013,144 $0.000100 $0.09 $0.09 1x $0.09 8.26%
To view Stamford Pharmaceuticals’s complete cap table history, request access »

Stamford Pharmaceuticals Executive Team (4)

Name Title Board Seat
Clement Leong Ph.D Chief Executive Officer & Director
Jacques Banchereau Ph.D Chief Scientific Officer
You’re viewing 2 of 4 executive team members. Get the full list »

Stamford Pharmaceuticals Board Members (6)

Name Representing Role Since
Andrew Strong JD Self Board Member 000 0000
Edward McKenna Self Board Member 000 0000
Michael Derby Self Board Member 000 0000
Michael Lamprecht Ph.D Tenmile Board Member 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Stamford Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stamford Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Prevail Partners Venture Capital Minority 000 0000 000000 0
Tenmile Venture Capital Minority 000 0000 000000 0
To view Stamford Pharmaceuticals’s complete investors history, request access »

Stamford Pharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
4G Vaccines 01-Jan-2012 0000000000 Drug Discovery
To view Stamford Pharmaceuticals’s complete acquisitions history, request access »

Stamford Pharmaceuticals FAQs

  • When was Stamford Pharmaceuticals founded?

    Stamford Pharmaceuticals was founded in 1995.

  • Who is the CEO of Stamford Pharmaceuticals?

    Clement Leong Ph.D is the CEO of Stamford Pharmaceuticals.

  • Where is Stamford Pharmaceuticals headquartered?

    Stamford Pharmaceuticals is headquartered in Austin, TX.

  • What is the size of Stamford Pharmaceuticals?

    Stamford Pharmaceuticals has 4 total employees.

  • What industry is Stamford Pharmaceuticals in?

    Stamford Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Stamford Pharmaceuticals a private or public company?

    Stamford Pharmaceuticals is a Private company.

  • What is the current valuation of Stamford Pharmaceuticals?

    The current valuation of Stamford Pharmaceuticals is 0000.

  • What is Stamford Pharmaceuticals’s current revenue?

    The current revenue for Stamford Pharmaceuticals is 000000.

  • How much funding has Stamford Pharmaceuticals raised over time?

    Stamford Pharmaceuticals has raised $33M.

  • Who are Stamford Pharmaceuticals’s investors?

    Prevail Partners and Tenmile have invested in Stamford Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »